Emily Egeler

Cancer Prevention Institute of California

Also affiliated with Stanford Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study”.

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

The Lancet(2024)10.1016/s0140-6736(24)00746-3

N/A

1.4DataRank · unranked

60 citations

John H. Baird, Anne Marijn Kramer, Hrishikesh K. Srinagesh, Shabnum Patel, Annie Kathleen Brown +43 more

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

Blood Advances(2023)10.1182/bloodadvances.2022008893

N/A

0.515DataRank · unranked

30 citations

Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J. Chen +28 more

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021006418

N/A

0DataRank · unranked

113 citations

Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler +27 more

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2022)10.1200/jco.22.01076

N/A

0DataRank · unranked

73 citations

Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K. Keating +26 more

Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel

Blood Advances(2025)10.1182/bloodadvances.2025016824

N/A

0DataRank · unranked

2 citations

Subodh Selukar, Aimee C. Talleur, Samira Deshpande, Gabriela Llaurador Caraballo, Vanessa A. Fabrizio +34 more